We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.77%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.54B
AUM Growth
-$135M
(-8.1%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-13.95%
Top 10 Holdings %
Top 10 Hldgs %
25.05%
Holding
1,512
New
379
Increased
290
Reduced
289
Closed
425
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$10.9M |
| 2 |
ARNC
Arconic Corporation
ARNC
|
+$7.33M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$7.14M |
| 4 |
NetEase
NTES
|
+$7.01M |
| 5 |
Micron Technology
MU
|
+$6.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$65.4M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$62.2M |
| 3 |
Li Auto
LI
|
+$29.4M |
| 4 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
+$15.1M |
| 5 |
Alibaba
BABA
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.1% |
| 2 | Consumer Discretionary | 11.71% |
| 3 | Healthcare | 9.05% |
| 4 | Industrials | 8.79% |
| 5 | Financials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Nano X Imaging
NNOX
$73.8M
| $219K | 0.01% |
14,153
-8,605
| -38% | -$119K |
|
802
Hilton Worldwide
HLT
$71.5B
| $219K | 0.01% |
1,506
-510
| -25% | -$72.6K |
|
803
Amylyx Pharmaceuticals
AMLX
$2.54B
| $218K | 0.01% |
10,100
+2,800
| +38% | +$75.6K |
|
804
Commercial Metals
CMC
$8.31B
| $217K | 0.01% |
+4,129
| New | +$193K |
|
|
AXON
805
Axon Enterprise
AXON
$46.4B
| $217K | 0.01% |
1,114
+100
| +10% | +$20.7K |
|
|
HEES
806
DELISTED
H&E Equipment Services
HEES
| $217K | 0.01% |
+4,748
| New | +$190K |
|
807
Union Pacific
UNP
$174B
| $217K | 0.01% |
+1,061
| New | +$211K |
|
808
NCR Voyix
VYX
$1.14B
| $217K | 0.01% |
+14,034
| New | +$202K |
|
809
Repay Holdings
RPAY
$327M
| $216K | 0.01% |
+27,591
| New | +$186K |
|
810
1-800-Flowers.com
FLWS
$258M
| $216K | 0.01% |
27,684
+10,436
| +61% | +$95.8K |
|
811
TFI International
TFII
$11.5B
| $215K | 0.01% |
+1,888
| New | +$207K |
|
812
Banner Corp
BANR
$2.4B
| $214K | 0.01% |
+4,910
| New | +$232K |
|
813
Global X Silver Miners ETF NEW
SIL
$4.74B
| $214K | 0.01% |
8,237
+62
| +0.8% | +$1.78K |
|
814
CVS Health
CVS
$122B
| $214K | 0.01% |
3,096
-2,818
| -48% | -$201K |
|
|
EXE
815
Expand Energy Corp
EXE
$21.5B
| $214K | 0.01% |
+2,555
| New | +$204K |
|
816
Quaker Houghton
KWR
$2.92B
| $214K | 0.01% |
+1,096
| New | +$214K |
|
817
United Natural Foods
UNFI
$2.85B
| $213K | 0.01% |
+10,917
| New | +$274K |
|
818
Adaptive Biotechnologies
ADPT
$3.97B
| $213K | 0.01% |
31,804
-3,650
| -10% | -$27.1K |
|
|
ETNB
819
DELISTED
89bio
ETNB
| $213K | 0.01% |
+11,232
| New | +$197K |
|
820
Urban Outfitters
URBN
$6.59B
| $213K | 0.01% |
+6,421
| New | +$187K |
|
821
Cemex
CX
$16.3B
| $212K | 0.01% |
30,000
| – | – |
|
822
Bentley Systems
BSY
$10.6B
| $212K | 0.01% |
+3,915
| New | +$183K |
|
823
UDR
UDR
$12.3B
| $212K | 0.01% |
+4,940
| New | +$203K |
|
|
CVSA
824
Covista Inc
CVSA
$4.8B
| $212K | 0.01% |
+6,180
| New | +$247K |
|
825
Sanara MedTech
SMTI
$313M
| $212K | 0.01% |
5,286
-1,239
| -19% | -$50.7K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Prelude Capital Management held 1,512 positions worth $1.54B, down 8.1% from $1.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Prelude Capital Management withdrew a net $214M in Q2 2023, closing 425 positions and reducing 289 holdings. Its most notable exit was Li Auto, an estimated $29.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in Arconic Corporation worth $7.86M.
- Prelude Capital Management's largest Q2 2023 buy was Arconic Corporation: 265,725 shares worth $7.86M.
- Prelude Capital Management added most to IVERIC bio, Inc. Common Stock in Q2 2023, an estimated $10.9M increase.
- Prelude Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $65.4M.
- Prelude Capital Management fully exited Li Auto in Q2 2023, selling an estimated $29.4M.
- Prelude Capital Management's ten largest holdings make up 25% of its $1.54B portfolio in Q2 2023.
- Prelude Capital Management opened 379 new positions and closed 425 in Q2 2023.
- Prelude Capital Management's portfolio value fell 8.1% quarter-over-quarter to $1.54B.
Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.